Friedemann Zengerling

Albert Einstein Allee 23
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 128 publications

Sex-Specific Differences in Disease-Free, Progression-Free and Overall Survival Following Enfortumab Vedotin Therapy for Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.

Sex-Specific Differences in Disease-Free, Progression-Free and Overall Survival Following Enfortumab Vedotin Therapy for Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.

Journal: Clinical genitourinary cancer

Published: May 21, 2026

Title Not Found

Title Not Found

Journal: Urologie (Heidelberg, Germany)

Published: March 09, 2026

Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS).

Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS).

Journal: Cancer immunology, immunotherapy : CII

Published: February 16, 2026

Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis.

Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Targeting mutant VHL-gene results in therapy response in metastatic clear cell carcinoma of rete testis.

Targeting mutant VHL-gene results in therapy response in metastatic clear cell carcinoma of rete testis.

Journal: Urology case reports

Published: January 25, 2026

Neoadjuvant therapy and complete response of muscle-invasive bladder cancer: may the urinary bladder be preserved?

Neoadjuvant therapy and complete response of muscle-invasive bladder cancer: may the urinary bladder be preserved?

Journal: Urologie (Heidelberg, Germany)

Published: January 11, 2026

CRISPR and compound screens in a novel ex vivo tissue model identify DDR1 and ETA as regulators of cancer cell invasion.

CRISPR and compound screens in a novel ex vivo tissue model identify DDR1 and ETA as regulators of cancer cell invasion.

Journal: Cellular & molecular biology letters

Published: December 01, 2025

Modern management of locally advanced urothelial carcinoma of the upper urinary tract.

Modern management of locally advanced urothelial carcinoma of the upper urinary tract.

Journal: World journal of urology

Published: September 30, 2025

Radiation Therapy Combined with Immunotherapy Before Radical Cystectomy in Locally Advanced Bladder Cancer: A Prospective, Single-arm, Multicenter, Phase 2 Trial (RACE-IT).

Radiation Therapy Combined with Immunotherapy Before Radical Cystectomy in Locally Advanced Bladder Cancer: A Prospective, Single-arm, Multicenter, Phase 2 Trial (RACE-IT).

Journal: European urology oncology

Published: September 15, 2025

First clinical application of silicon-based [¹⁸F]siPSMA-14 in prostate cancer patients: A proof-of-concept study.

First clinical application of silicon-based [¹⁸F]siPSMA-14 in prostate cancer patients: A proof-of-concept study.

Journal: Nuklearmedizin. Nuclear medicine

Published: September 05, 2025

Testicular germ cell tumors-stage-specific treatment for long-term quality of life

Testicular germ cell tumors-stage-specific treatment for long-term quality of life

Journal: Urologie (Heidelberg, Germany)

Published: August 19, 2025

Gender-specific differences in outcome and survival in early cystectomy : Systematic review

Gender-specific differences in outcome and survival in early cystectomy : Systematic review

Journal: Urologie (Heidelberg, Germany)

Published: July 15, 2025

Showing 1-12 of 128

Last Updated: 09/26/2026